Sermorelin Injections: How They Are Given in Studies and What Is Unknown
Sermorelin is a growth hormone releasing peptide given as a shot under the skin. The research behind it is older and smaller than online pages imply.
Words by the editors ·
Sponsored
Sermorelin injections are shots of a synthetic peptide that mimics growth hormone releasing hormone (GHRH). The peptide is injected under the skin, usually at night in the studies we found, and it prompts the pituitary gland to release growth hormone rather than supplying the hormone itself.1 The research is mostly from children with a diagnosed deficiency and a few small adult trials, and no FDA-reviewed label for sermorelin appeared in a DailyMed search, so adults who receive it get a compounded product.34
In brief
- Sermorelin is a 29 amino acid analogue of growth hormone releasing hormone that stimulates the pituitary to release growth hormone, and it has been given both intravenously and under the skin.1
- In children with growth hormone deficiency it was injected under the skin once daily at bedtime, and the most common adverse events were transient facial flushing and pain at the injection site.1
- In a 5-month trial of 19 adults aged 55 to 71, a related GHRH analog injected nightly raised IGF-I and, in men only, lean body mass, while sleep quality was unaffected.2
- A DailyMed search on October 30, 2026 listed no sermorelin label, and the FDA says compounded drugs are not FDA-approved.34
What are sermorelin injections?
Sermorelin is a 29 amino acid analogue of human GHRH, described in a 1999 review as the shortest synthetic peptide with full biological activity of GHRH. Given by vein or under the skin, it stimulates growth hormone secretion from the anterior pituitary.1 That separates it from growth hormone injections (somatropin), which replace the hormone directly. How sermorelin differs from related peptides is covered in sermorelin vs ipamorelin and sermorelin vs tesamorelin, and the basics are in what sermorelin is.
How were sermorelin injections given in studies?
| Setting | How it was given | What was reported |
|---|---|---|
| Diagnostic test for growth hormone deficiency | One intravenous dose of 1 microgram per kilogram1 | A normal response cannot exclude a hypothalamic deficit1 |
| Children with idiopathic growth hormone deficiency | 30 micrograms per kilogram once daily under the skin at bedtime, or as a continuous infusion or three divided doses1 | Height velocity rose during 12 months, but final adult height was not determined and gains were smaller than with somatropin1 |
| Adults aged 55 to 71 (19 people, placebo-controlled for 5 months) | A GHRH analog, [Nle27]GHRH-(1-29)-NH2, 10 micrograms per kilogram, self-injected under the skin nightly for 16 weeks after 4 weeks of saline2 | Higher GH and IGF-I; lean body mass up in men only; sleep quality unaffected2 |
Two cautions apply to that last row. The adult trial used a GHRH analog closely related to sermorelin, not a compounded sermorelin product, and the dose was weight-based in a research setting.2 The doses are covered in more detail in sermorelin dosage: what published studies report.
What happens after an injection?
In the older adult trial, a nightly injection at 9 pm produced an acute release of growth hormone within 10 minutes that lasted about 2 hours, and the response was sustained over the study.2 IGF-I and IGFBP-3, markers of the growth hormone axis, rose within weeks.2 That is a lab response. It is not the same as a change in how a man looks or feels, which is a separate question covered in sermorelin benefits sorted by evidence.
What side effects do sermorelin injections cause?
The pediatric review called single intravenous and repeated once-daily subcutaneous doses well tolerated, with transient facial flushing and pain at the injection site the most commonly reported adverse events.1 In the adult trial the only adverse effect reported was transient hyperlipidemia, which resolved by the end of the study, and skin thickness measured by calipers increased.2 A broader review of growth hormone secretagogues noted few long-term controlled studies and raised concern about insulin sensitivity and the need for long-term safety data, including cancer incidence.5 The full list is in sermorelin side effects: what studies report.
Are sermorelin injections FDA-approved?
We could not find an approved sermorelin product. A DailyMed search on October 30, 2026 returned no sermorelin labels.3 The FDA states that compounded drugs are not FDA-approved and are not reviewed for safety and effectiveness.4 An injection prepared by a compounding pharmacy for one prescription is therefore not the product that was studied in children, and its strength and purity are the pharmacy's responsibility. A 2026 endocrinology review of peptides acting on the growth hormone axis warned about uncertain composition and dosing in unregulated supply chains.6
How do you measure and inject a dose correctly?
Follow the prescriber and pharmacy label, not a website. Sermorelin is dosed in micrograms of peptide, so a volume in mL or syringe units only means something once you know the vial strength. The FDA documented dosing errors with compounded injectable semaglutide, a different drug, caused by patients measuring incorrect doses, and advises asking the provider or compounder how to measure the intended dose.7 We found no label or trial that sets injection-site rotation, needle size or storage for sermorelin, so ask the pharmacy for written instructions for the exact product it supplies.
Who should not start without a clinician's review?
A prescriber should know about any history of cancer, pituitary or thyroid disease, or diabetes, because growth hormone axis treatments carry open questions in those settings.5 A clinician should also decide whether any test supports looking at the growth hormone axis at all, since the studied use is a diagnosed deficiency.1 Whether the whole idea is worth pursuing is the subject of is sermorelin worth it. If you would rather avoid needles, see sermorelin tablets.
Sponsored: sermorelin injections from Vea Health, one prescriber route
This section is sponsored: we have a financial relationship with Vea Health. It is one route among several and not a recommendation over talking to your own clinician.
Vea Health says it offers sermorelin injections prescribed by a licensed clinician after an online health questionnaire, filled by a state-licensed U.S. compounding pharmacy, and that you are not charged unless a clinician approves the prescription.8 The page we loaded does not state a dose, vial strength or schedule, so what a prescription would specify is for the clinician to decide. Compounded sermorelin is not FDA-approved.4
Bottom line
Sermorelin injections have a real but narrow evidence base: a diagnostic test, a pediatric deficiency, and a small adult trial of a related analog that moved growth hormone markers. Adult use today relies on compounded products without a label, so the useful questions are who prescribes it, which pharmacy fills it and what will be measured and when it is reassessed.
Questions
What do sermorelin injections do?
Sermorelin stimulates the pituitary gland to release growth hormone. In studies this raised growth hormone and IGF-I levels; whether that improves how an adult feels or looks is much less established.
Are sermorelin injections subcutaneous?
Yes. The pediatric studies gave 30 micrograms per kilogram once daily under the skin at bedtime, and the adult trial of a related analog used nightly subcutaneous self-injection.
What are the side effects of sermorelin injections?
Transient facial flushing and pain at the injection site were the most common adverse events in children. The adult trial reported transient hyperlipidemia and thicker skin.
Is sermorelin FDA-approved?
A DailyMed search on October 30, 2026 returned no sermorelin labels. Compounded versions are not FDA-approved.
How many days a week do you take sermorelin?
No label or controlled adult trial sets a schedule. The studies we found gave it nightly, and a prescriber sets any real plan.
Also in this edition
Part of our guide: Sermorelin: The Complete Guide
Notes
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999. PubMed 18031173.
- Khorram O, Laughlin GA, Yen SS. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997. PubMed 9141536.
- Sermorelin search. DailyMed, U.S. National Library of Medicine. Searched October 30, 2026.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
- Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sex Med Rev. 2018. PubMed 28400207.
- Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol. 2026. PubMed 42395176.
- U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
- Vea Health. Sermorelin intake. Accessed October 9, 2026.